Pacer Advisors Inc. Increases Holdings in Cabot Corporation $CBT

Pacer Advisors Inc. increased its position in Cabot Corporation (NYSE:CBT) by 3,165.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 229,252 shares of the specialty chemicals company’s stock after purchasing an additional 222,232 shares during the quarter. Pacer Advisors Inc.’s holdings in Cabot were worth $15,195,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Torren Management LLC purchased a new stake in shares of Cabot in the 4th quarter worth $26,000. Rothschild Investment LLC increased its stake in shares of Cabot by 170.4% during the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after buying an additional 259 shares during the period. Geneos Wealth Management Inc. increased its stake in shares of Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 364 shares during the period. Global Retirement Partners LLC raised its holdings in shares of Cabot by 1,606.9% in the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after acquiring an additional 466 shares in the last quarter. Finally, Danske Bank A S bought a new stake in shares of Cabot in the third quarter valued at about $38,000. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Trading Down 0.4%

Shares of NYSE CBT opened at $91.43 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96. The stock has a market capitalization of $4.72 billion, a P/E ratio of 17.28, a price-to-earnings-growth ratio of 12.07 and a beta of 0.82. Cabot Corporation has a 1-year low of $58.33 and a 1-year high of $91.80. The business has a fifty day moving average price of $81.52 and a 200 day moving average price of $74.78.

Cabot (NYSE:CBT) last posted its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The company had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.30 million. During the same quarter in the previous year, the firm earned $1.90 earnings per share. The firm’s quarterly revenue was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Equities research analysts expect that Cabot Corporation will post 6.34 EPS for the current fiscal year.

Cabot Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Friday, May 29th were issued a $0.4725 dividend. The ex-dividend date was Friday, May 29th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.1%. This is an increase from Cabot’s previous quarterly dividend of $0.45. Cabot’s dividend payout ratio (DPR) is 35.73%.

Analyst Ratings Changes

CBT has been the topic of several recent research reports. UBS Group increased their target price on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a report on Friday, May 8th. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a report on Tuesday, May 26th. Truist Financial initiated coverage on shares of Cabot in a research report on Monday, June 8th. They issued a “buy” rating and a $98.00 price target for the company. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. Finally, Mizuho lifted their price objective on shares of Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $83.80.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.